MANNKIND CORP (MNKD)
$0.00+$0.00 (+0.00%) TodayExtended Hours
Dominic Marasco - OfficerMannKind Corp is a biopharmaceutical company focused on the development and commercialization of patient-centric therapies that address serious unmet medical needs for those living with cardiometabolic and orphan lung diseases. The Company is currently commercializing three products: Afrezza (insulin human) Inhalation Powder, an ultra rapid-acting inhaled insulin indicated to improve glycemic control in adults with diabetes; Furoscix (furosemide injection), to treat fluid buildup in patients with chronic heart failure or chronic kidney disease; and the V-Go wearable insulin delivery device, which provides continuous subcutaneous infusion of insulin in adults that require insulin.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 3 | 115,645 | $469K |
| Option exercise | 10 | 1,404,360 | |
| Tax withholding / forfeiture | 22 | 624,494 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
69 Form 4 filings on record, the earliest from Nov 4, 2024, newest first. Filing history page 3 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| David Thomson - Officer | Grant or award | Common Stock, $0.01 Par Value | 105,600 | $0.00 | - | |
| David Thomson - Officer | Tax withholding / forfeiture | Common Stock, $0.01 Par Value | 118,473 | $4.56 | $540K | |
| David Thomson - Officer | Tax withholding / forfeiture | Common Stock, $0.01 Par Value | 12,364 | $4.56 | $56K | |
| David Thomson - Officer | Open-market sale | Common Stock, $0.01 Par Value | 32,179 | $4.68 | $151K | |
| David Thomson - Officer | Grant or award | Common Stock, $0.01 Par Value | 119,000 | $0.00 | - | |
| David Thomson - Officer | Grant or award | Performance Restricted Stock Unit | 145,000 | $0.00 | - | |
| Michael A. Friedman | Grant or award | Restricted Stock Unit | 52,854 | $0.00 | - | |
| Ronald J. Consiglio | Grant or award | Restricted Stock Unit | 52,854 | $0.00 | - | |
 Christine Mundkur | Grant or award | Restricted Stock Unit | 52,854 | $0.00 | - | |
| Anthony C. Hooper | Grant or award | Common Stock, $0.01 Par Value | 25,000 | $4.56 | $114K | |
| Anthony C. Hooper | Grant or award | Restricted Stock Unit | 52,854 | $0.00 | - | |
| Anthony C. Hooper | Grant or award | Restricted Stock Unit | 10,571 | $0.00 | - | |
| Steven B. Binder | Option exercise | Common Stock, $0.01 Par Value | 67,536 | $1.47 | $99K | |
| Steven B. Binder | Open-market sale | Common Stock, $0.01 Par Value | 67,536 | $6.89 | $465K | |
| Steven B. Binder | Option exercise | Employee Stock Option (Right to Buy) | 22,512 | $0.00 | - | |
| Steven B. Binder | Option exercise | Employee Stock Option (Right to Buy) | 22,512 | $0.00 | - | |
| Steven B. Binder | Option exercise | Employee Stock Option (Right to Buy) | 22,512 | $0.00 | - | |
| Steven B. Binder | Option exercise | Common Stock, $0.01 Par Value | 67,539 | $1.47 | $99K | |
| Steven B. Binder | Open-market sale | Common Stock, $0.01 Par Value | 67,539 | $6.76 | $457K | |
| Steven B. Binder | Grant or award | Employee Stock Option (Right to Buy) | 45,025 | $0.00 | - | |
| Steven B. Binder | Option exercise | Employee Stock Option (Right to Buy) | 22,513 | $0.00 | - | |
| Steven B. Binder | Option exercise | Employee Stock Option (Right to Buy) | 22,513 | $0.00 | - | |
| Steven B. Binder | Option exercise | Employee Stock Option (Right to Buy) | 22,513 | $0.00 | - | |
| Steven B. Binder | Grant or award | Deferred Restricted Stock Unit | 17,575 | $0.00 | - | |
| Stuart A. Tross - Officer | Open-market sale | Common Stock, $0.01 Par Value | 55,000 | $7.34 | $404K | |
| Sanjay R. Singh - Officer | Tax withholding / forfeiture | Common Stock, $0.01 Par Value | 17,071 | $7.07 | $121K |
This is as far as the anonymous view goes. Create a free account for all 69 MNKD filings on record.
A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| STEVEN BINDER | Director | 39,051 | $152K | View on EDGAR | |
| - | - | - | - | View on EDGAR | |
| - | - | - | - | View on EDGAR |
MANNKIND CORP (MNKD) had 8 insider filings in the last 90 days, with the most recent on 2026-08-11. The full record for MNKD runs to 69 Form 4 filings, the earliest from 2024-11-04. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of MNKD were filed in the last 90 days. 1 purchase is on record for this company.
3 insider sales of MNKD were filed in the last 90 days, totaling $469K.
This page tracks MNKD Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add MNKD to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
